Definitive Radiation for High-Risk Spine Metastases
Recruiting
Phase 2
Interventional Study
Metastatic Cancer
Metastatic Lung Cancer
Metastatic Breast Cancer
Metastatic Tumor
Metastatic Tumor of Bone
Metastatic Tumor to the Spine
Spine Metastases
Metastasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 26 (estimated)
- Sponsor
- Stony Brook University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Eligible patients must have:
* Any pathologically proven solid tumor diagnosis not of central nervous system origin with radiographic or pathologic evidence of metastatic disease
* Metastatic spine involvement documented by imaging
* Involvement of maximum 3 contiguous vertebral bodies at the index…
Contacts